Early initiation of antiretroviral treatment: Challenges in the Middle East and North Africa

doi:10.5501/wjv.v4.i2.134

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7406)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

647

WORD

310

HTML

3277

Figures (1-1)

300

Tables (1-1)

271

Sum=4805

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1036

Download

1565

Sum=2601

May 12, 2015 (publication date) through Feb 27, 2025

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Virology. May 12, 2015; 4(2): 134-141
Published online May 12, 2015. doi: 10.5501/wjv.v4.i2.134

Full Size Figure Download Figure

Figure 1 Major challenge for development of human immunodeficiency virus treatment guidelines in Middle East and North Africa. MENA: Middle East and North Africa; ART: Antiretroviral treatment.

Citation: Sardashti S, Samaei M, Firouzeh MM, Mirshahvalad SA, Pahlaviani FG, SeyedAlinaghi S. Early initiation of antiretroviral treatment: Challenges in the Middle East and North Africa. World J Virology 2015; 4(2): 134-141
URL: https://www.wjgnet.com/2220-3249/full/v4/i2/134.htm
DOI: https://dx.doi.org/10.5501/wjv.v4.i2.134